Over-expression of Grhl2 correlates with shorter relapse-free survival interval and increased risk of metastasis in breast cancer patients.Xiaoyu, Xiang
Patients with TNBC had statistically significant shorter recurrence-free survival [hazard ratio (HR) = 1.8; P = 0.0023], breast cancer-corrected survival (HR = 2.2; P = 0.004) and overall survival (HR = 1.8; P = 0.005) compared with non-TNBC. Patients with TNBC relapsed earlier than non...
High serum interleukin-6 levels correlate with a shorter failure-free survival in indolent lymphoma High serum interleukin-6 levels correlate with a shorter failure-free survival in indolent lymphoma. Leuk Lymphoma. 1998;30(5–6):563–71... L Fayad,F Cabanillas,M Talpaz,... - 《Leukemia &...
For survival analysis, two endpoints (cancer relapse/progression and death for cancer) were used to calculate progression-free survival (PFS) and disease-specific overall survival (OS), respectively. Cox proportional hazard model23 was used for survival analysis, while Kaplan–Meier method24 was ...
PSA-relapse-free survival in dependence of (A) Gleason grade, (B) HDAC1, (C) HDAC2 and (D) HDAC3 expression. P-values were calculated with the log-rank test. Full size image The effect of HDAC2 on patient prognosis became even more pronounced in the multivariate survival analysis (...
The 5-year Overall survival, event-free survival, and leukemia-free survival was 93%, 89%, and 92%, respectively. 关键词: All-trans retinoic acid Anthracyclines APL ATO Promyelocytic leukemia-retinoic acid receptor alpha 年份: 2015 收藏 引用 批量引用 报错 分享 全部来源 求助全文 掌桥科研 ...
In the entire cohort, mutated DNMT3A associated with shorter relapse-free survival (RFS, hazard ratio [HR], 1.64, P P =.02). Outcomes were similar for pts with DNMT3A codon R882 mutations, other missense mutations, or truncating mutations. Shorter RFS and OS of DNMT3A -mutated pts was ...
After adjusting for patient age, tumor subtype, tumor grade, and clinical stage, we found that patients with primary breast cancers expressing high SCD1 levels had significantly shorter relapse-free survival (RFS) (P = 0.014) and overall survival (OS) (P = 0.039) in multivariable analysis. ...
Epigenetic Homogeneity Within Colorectal Tumors Predicts Shorter Relapse-Free and Overall Survival Times for Patients With Locore- gional Cancer. Gastroenterology. 2016;151:961-972. .doi:10.1053/j. gastro.2016.08.001. PMID:27521480Martinez-Cardus A, Moran S, Musulen E, et al. Epigenetic ...
et al. Association of telomere length of peripheral blood leukocytes with hematopoietic relapse, malignant transformation, and survival in severe aplastic anemia. JAMA 304, 1358–1364 (2010). 55. Heidinger, B. J. et al. Telomere length in early life predicts lifespan. Proc. Natl. Acad. Sci....